School of Medicine

A WashU Medicine neuroscientist and fan of the Philadelphia Eagles, Jason Yi, has received a $400,000 grant to study autism spectrum disorder from the football team’s foundation.

WashU Medicine researchers showed that a popular antidepressant drug effectively reduced seizures for two sisters with a rare form of epilepsy.

A WashU Medicine study paves the way to make an effective treatment more accessible to those ‘paralyzed by life.’

WashU scientists are collaborating to unlock secrets of a millennia-old scourge. Efforts may lead to an increased understanding of and improved treatments for tuberculosis, which is once again on the rise.

Eric J. Lenze, MD, and his team at WashU Medicine’s Healthy Mind Lab are among 40 semifinalists in the XPRIZE Healthspan competition awarded $250,000 to study approaches to improve healthy aging.

Hong Chen, a biomedical engineer at WashU, shares the potential for using synthetic torpor technology to develop new treatments for a range of illnesses and injuries.

A new study by WashU Medicine researchers found that, in mice, histamine-releasing immune cells protect the brain from infection.

A team led by WashU Medicine radiology associate professor Shuo Wang has identified neurons that appear to play a key role in our ability to recognize people.

AI-based technology developed at WashU Medicine that improves breast cancer risk prediction has received Breakthrough Device designation from the Food and Drug Administration.

Chancellor Andrew D. Martin has appointed a committee to begin the process of identifying the next dean of WashU Medicine. David H. Perlmutter, MD, will conclude his deanship in June 2026.